GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige Biologics Co Ltd (XKRX:334970) » Definitions » Accounts Payable & Accrued Expense

Prestige Biologics Co (XKRX:334970) Accounts Payable & Accrued Expense : ₩7,868 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Prestige Biologics Co Accounts Payable & Accrued Expense?

Prestige Biologics Co's quarterly accounts payable & accrued expense increased from Mar. 2024 (₩9,406 Mil) to Jun. 2024 (₩10,736 Mil) but then declined from Jun. 2024 (₩10,736 Mil) to Sep. 2024 (₩7,868 Mil).

Prestige Biologics Co's annual accounts payable & accrued expense declined from Dec. 2022 (₩15,899 Mil) to Jun. 2023 (₩7,593 Mil) but then increased from Jun. 2023 (₩7,593 Mil) to Jun. 2024 (₩10,736 Mil).

Prestige Biologics Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Prestige Biologics Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige Biologics Co Accounts Payable & Accrued Expense Chart

Prestige Biologics Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Jun23 Jun24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only 1,016.37 19,534.54 15,899.27 7,592.95 10,735.93

Prestige Biologics Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,516.82 9,890.94 9,405.82 10,735.93 7,868.08

Prestige Biologics Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Prestige Biologics Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige Biologics Co Ltd (XKRX:334970) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
XKRX:216080 XKRX:115450 XKRX:228760 XKRX:199800 XKRX:095700 XKRX:397030 XKRX:048870 XKRX:053030 XKRX:011000 XKRX:060590 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
197, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Chungcheongbuk-do, Cheongju-si, KOR, 28161
Website
https://www.prestigebiologics.com
Prestige Biologics Co Ltd is a CDMO-dedicated company that provides solutions of development and manufacturing tasks throughout the stages from the research/development, engineering, clinical production, commercial production, clinical support, and IND & BLA filing of biopharmaceutical products. Its product candidate includes HD201 (Herceptin Biosimilar).

Prestige Biologics Co Headlines

No Headlines